1. Molecular profiling of post-pembrolizumab muscle-invasive bladder cancer reveals unique features that may inspire new sequential therapies in nonresponders. (October 2020) Authors: Marandino, L.; de Jong, J.J.; Raggi, D.; Gallina, A.; Bandini, M.; Giannatempo, P.; Colecchia, M.; Briganti, A.; Montorsi, F.; Davicioni, E.; Seiler, R.; Black, P.; Gibb, E.A.; Necchi, A. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗